Browse > Article
http://dx.doi.org/10.15432/JKTO.2020.25.1.011

A Literature Review of Management on Radiodermatitis  

Kwon, Mi Hye (Department of Korean Internal Medicine, Korean Medicine Cancer Center, Kyung Hee University Hospital at Gangdong)
Yoon, Jee-Hyun (Department of Korean Internal Medicine, Korean Medicine Cancer Center, Kyung Hee University Hospital at Gangdong)
Kim, Eun Hye (Department of Korean Internal Medicine, Korean Medicine Cancer Center, Kyung Hee University Hospital at Gangdong)
Lee, Jee Young (Department of Korean Internal Medicine, Korean Medicine Cancer Center, Kyung Hee University Hospital at Gangdong)
Yoon, Seong Woo (Department of Korean Internal Medicine, Korean Medicine Cancer Center, Kyung Hee University Hospital at Gangdong)
Publication Information
Journal of Korean Traditional Oncology / v.25, no.1, 2020 , pp. 11-24 More about this Journal
Abstract
Objective : Radiodermatitis is a common sequelae in 95% of patients receiving radiation therapy, which is important to be well managed as it can affect the patient's quality of life as well as the cancer treatment schedule. The aim of this study is to review and summarize the interventions available for the treatment of acute radiodermatitis, including traditional Korean medicine, and to propose treatment algorithms for clinicians. Methods : To collect studies about managements for radiodermatitis, domestic and foreign database were used such as Korean journal of traditional knowledge portal (KTKP), Korean studies information service system (KISS), national discovery or science leaders (NDSL), and oriental medicine advance searching integrated system (OASIS), Pubmed, Google scholar and Scopus. Results : Thirty-two studies were selected. There were nine studies on usual care and dressing, eleven studies on chemical agents, two studies on biological preparations, and ten studies on herbal medicines. Conclusion : Hygienic options and dressings have proved to be useful in the management of radiodermatitis. Chemical agents such as corticosteroid, statin, and topical antibiotic agent have proved to alleviate symptoms and severity, regenerate damaged skin, and prevent secondary infection. In biological preparations, EGF (epidermal growth factor) and GM-CSF (granulocyte-macrophage colony-stimulating factor) could be used to protect skin and prevent radiodermatitis. For herbal medicines, Calendula, catechin, β-sitosterol, and Jaungo (紫雲膏) may be effective for symptoms including pain, itching, and burning sensation induced by radiation therapy. Because of some research with conflicting results, further studies are needed to propose an algorithm for more optimal treatments.
Keywords
Radiodermatitis; Literature review; Radiation therapy; Cancer; Traditional Korean medicine;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Lee SE, Lew W. A case of radiation recall dermatitis which developed in a patient with Kaposi sarcoma. Korean J Dermatol 46(8):1141-1144, 2008
2 Wei J, Meng L, Hou X, Qu C, Wang B, Xin Y, Jiang X. Radiation-induced skin reactions: mechanism and treatment. Cancer Manag Res 11:167-177, 2018.   DOI
3 Pignol JP, Olivotto I, Rakovitch E, Gardner S, Sixel K, Beckham W, Vu TTT, Truong P, Ackerman I, Paszat L. A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis. J Clin Oncol 26(13):2085-2092, 2008   DOI
4 Hindley A, Zain Z, Wood L, Whitehead A, Sanneh A, Barber D, Hornsby R. Mometasone furoate cream reduces acute radiation dermatitis in patients receiving breast radiation therapy: results of a randomized trial. Int J Radiat Oncol Biol Phys 90(4):748-755, 2014   DOI
5 Campbell IR, Illingworth MH. Can patients wash during radiotherapy to the breast or chest wall? A randomized controlled trial. Clin Oncol 4(2):78-82, 1992   DOI
6 Roy I, Fortin A, Larochelle M. The impact of skin washing with water and soap during breast irradiation: a randomized study. Radiother Oncol. 58(3):333-339, 2001   DOI
7 Theberge V, Harel F, Dagnault A. Use of axillary deodorant and effect on acute skin toxicity during radiotherapy for breast cancer: a prospective randomized noninferiority trial. Int J Radiat Oncol Biol Phys 75(4):1048-1052, 2009   DOI
8 O'Donovan A, Coleman M, Harris R, Herst P. Prophylaxis and management of acute radiation-induced skin toxicity: a survey of practice across Europe and the USA. Eur J Cancer Care (Engl) 24(3):425-435, 2015   DOI
9 Leventhal J, Young MR. Radiation dermatitis: Recognition, prevention, and management. Oncology (Williston Park) 31(12):885-899, 2017
10 Chan RJ, Webster J, Chung, B, Marquart L, Ahmed M, Garantziotis S. Prevention and treatment of acute radiation-induced skin reactions: a systematic review and meta-analysis of randomized controlled trials. BMC Cancer 14(53), 2014.
11 Burch SE, Parker SA, Vann AM, Arazie JC. Measurement of 6-MV X-ray surface dose when topical agents are applied prior to external beam irradiation. Int J Radiat Oncol Biol Phys 38(2):447-451, 1997   DOI
12 Bennett C. An investigation into the use of a non-metallic deodorant during radiotherapy treatment: a randomised controlled trial. J Radiother Prac 8(1):3-9, 2009   DOI
13 Gee A, Churn M, Errington RD. A randomised controlled trial to test a non-metallic deodorant used during a course of radiotherapy. J Radiother Prac 1(4):205-212, 2000   DOI
14 Niazi TM, Vuong T, Azoulay L, Marijnen C, Bujko K, Nasr E, Lambert C, Duclos M, Faria S, David M, Cummings B. Silver clear nylon dressing is effective in preventing radiation-induced dermatitis in patients with lower gastrointestinal cancer: results from a phase III study. Int J Radiat Oncol Biol Phys 84(3):e305-e310, 2012   DOI
15 Rosenthal A, Israilevich R, Moy R. Management of acute radiation dermatitis: a review of the literature and proposal for treatment algorithm. J Am Acad Dermatol 81(2) :558-67, 2019   DOI
16 Ho AY, Olm-Shipman M, Zhang Z, Siu CT, Wilgucki M, Phung A, Arnold BB, Porinchak M, Lacouture M, McCormick B, Powell SN, Gelblum DY. A randomized trial of mometasone furoate 0.1% to reduce high-grade acute radiation dermatitis in breast cancer patients receiving postmastectomy radiation. Int J Radiat Oncol Biol Phys 101(2): 325-333, 2018   DOI
17 Haruna F, Lipsett A, Marignol L. Topical management of acute radiation dermatitis in breast cancer patients: a systematic review and meta-analysis. Anticancer Res 37(10):5343-5353, 2017
18 Liguori V, Guillemin C, Pesce GF, Mirimanoff RO, Bernier J. Double-blind, randomised clinical study comparing hyaluronic acid cream to placebo in patients treated with radiotherapy. Radiother Oncol 42(2):155-161, 1997   DOI
19 Pinnix C, Perkins GH, Strom EA, Tereffe W, Woodward W, Oh JL, Arriaga L, Munsell MF, Kelly P, Hoffman KE, Smith BD, Buchholz TA, Yu TK. Topical hyaluronic acid vs. standard of care for the prevention of radiation dermatitis after adjuvant radiotherapy for breast cancer: single-blind randomized phase III clinical trial. Int J Radiat Oncol Biol Phys 83(4):1089-1094, 2012   DOI
20 Kirova YM, Fromantin I, de Ricke Y, Fourquet A, Movan E, Padiglione S, Ealcou MC, Campana F, Bollet MA. Can we decrease the skin reaction in breast cancer patients using hyluronic acid during radiation therapy? Results of phase III randomised trial. Radiother Oncol 100(2):205-209, 2011   DOI
21 Ghasemi A, Ghashghai Z, Akbari J, Yazdani-Charati J, Salehifar E, Hosseinimehr SJ. Topical atorvastatin 1% for prevention of skin toxicity in patients receiving radiation therapy for breast cancer: a randomized, double-blind, placebo-controlled trial. Eur J Clin Pharmacol 75(2):171-178, 2019   DOI
22 Elliott EA, Wright JR, Swann RS, Nguyen-Tân F, Takita C, Bucci MK, Garden AS, Kim H, Hug EB, Ryu J, Greenberg M, Saxton JP, Ang K, Berk L. Phase III Trial of an emulsion containing trolamine for the prevention of radiation dermatitis in patients with advanced squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Trial 99-13. J Clin Oncol 24(13):2092-2097, 2006   DOI
23 Wells M, Macmillan M, Raab G, MacBride S, Bell N, MacKinnon K, MacDougall H, Samuel L, Munro A. Does aqueous or sucralfate cream affect the severity of erythematous radiation skin reactions? A randomised controlled trial. Radiother Oncol 73(2):153-162, 2004   DOI
24 Freedman GM, Radiation complications and their management, 716-725, In The Breast, Elsevier, 2018
25 Kouvaris JR, Kouloulias VE, Plataniotis GA, Kokakis JD, Vlahos LJ. Topical granulocyte-macrophage colonystimulating factor for radiation dermatitis of the vulva. Br J Dermatol 144(3):646-647, 2001   DOI
26 Hemati S, Asnaashari O, Sarvizadeh M, Motlagh BN, Akbari M, Tajvidi M, Gookizadeh A. Topical silver sulfadiazine for the prevention of acute dermatitis during irradiation for breast cancer. Support Care Cancer 20(8): 1613-1618, 2012   DOI
27 Chan RJ, Blades R, Jones L, Downer TR, Peet SC, Button E, Wyld D, McPhail S, Doolan M, Yates P. A single-blind, randomised controlled trial of StrataXRT(R) - A silicone-based film-forming gel dressing for prophylaxis and management of radiation dermatitis in patients with head and neck cancer. Radiother Oncol 139;72-78, 2019   DOI
28 Kang HC, Ahn SD, Choi DH, Kang MK, Chung WK, Wu HG. The safety and efficacy of EGF-based cream for the prevention of radiotherapy-induced skin injury: results from a multicenter observational study. Radiat Oncol J 32(3):156-162, 2014   DOI
29 Pommier P, Gomez F, Sunyach MP, D’'Hombres A, Carrie C, Montbarbon X. Phase III randomized trial of Calendula officinalis compared with trolamine for the prevention of acute dermatitis during irradiation for breast cancer. J Clin Oncol 22(8):1447-1453, 2004   DOI
30 Scalia S, Marchetti N, Bianchi A. Comparative evaluation of different co-antioxidants on the photochemical- and functional-stability of epigallocatechin-3-gallate in topical creams exposed to simulated sunlight. Molecules 18(1): 574-587, 2013   DOI
31 Zhao H, Zhu W, Jia L, Sun X, Chen G, Zhao X, Li X, Meng X, Kong L, Xing L, Yu J. Phase I study of topical epigallocatechin-3-gallate (EGCG) in patients with breast cancer receiving adjuvant radiotherapy. Br J Radiol 89(1058): 20150665, 2016   DOI
32 Ferreira EB, Ciol MA, Vasques CI, Bontempo Pde S, Vieira NN, Silva LF, Avelino SR, Dos Santos MA, Dos Reis PE. Gel of chamomile vs. urea cream to prevent acute radiation dermatitis in patients with head and neck cancer: a randomized controlled trial. J Adv Nurs. 72(8):1926-1934, 2016   DOI
33 Williams MS, Burk M, Loprinzi CL, Hill M, Schomberg PJ, Nearhood K, O'Fallon JR, Laurie JA, Shanahan TG, Moore RL, Urias RE, Kuske RR, Engel RE, Eggleston WD. Phase III double-blind evaluation of an Aloe vera gel as a prophylactic agent for radiation-induced skin toxicity. Int J Radiat Oncol Biol Phys 36(2):345-349, 1996   DOI
34 Heggie S, Bryant GP, Tripcony L, Keller J, Rose P, Glendenning M, Heath J. A phase III study on the efficacy of topical aloe vera gel on irradiated breast tissue. Cancer Nurs 25(6):442-451, 2002   DOI
35 Fisher J, Scott C, Stevens R, Marconi B, Champion L, Freedman GM, Asrari F, Pilepich MV, Gagnon JD, Wong G. Randomized phase III study comparing best supportive care to Biafine as a prophylactic agent for radiation- induced skin toxicity for women undergoing breast irradiation: Radiation Therapy Oncology Group (RTOG) 97-13. Int J Radiat Oncol Biol Phys 48(5):1307-1310, 2000   DOI
36 Maiche AG, Grohn P, Maki-Hokkonen H. Effect of chamomile cream and almond ointment on acute radiation skin reaction. Acta Oncol 30(3):395-397, 1991   DOI
37 Geara FB, Eid T, Zouain N, Thebian R, Andraos T, Chehab C, Ramia P, Youssef B, Zeidan YH. Randomized, prospective, open label phase III trial comparing Mebo ointment with Biafine cream for the management of acute dermatitis during radiotherapy for breast cancer. Am J Clin Oncol 41(12):1257-1262, 2018   DOI
38 Kong M, Hwang DS, Lee JY, Yoon SW. The efficacy and safety of Jaungo, a traditional medicinal ointment, in preventing radiation dermatitis in patients with breast cancer: a prospective, single-blinded, randomized pilot study. Evid Based Complement Alternat Med 2016:9481413, 2016